ITGAM and chronic kidney disease: We examined the expression of frequently reported main ligands and found a significant upregulation of ICAM‐1 and fibronectin (Figures 1F and S4A, B), which indicated potential role of ITGAM in cell–ECM and cell–cell interactions in kidneys of hyperuricemia‐related CKD.